Patents Assigned to Allergan Sales, LLC
  • Ketorolac tromethamine compositions for treating or preventing ocular pain
    Patent number: 8906950
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 9, 2014
    Assignee: Allergan Sales, LLC
    Inventors: Christopher A. Muller, Janet K. Cheetham, Teresa H. Kuan, David F. Power
  • Combination of brimonidine and timolol for topical ophthalmic use
    Patent number: 8748425
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: June 10, 2014
    Assignee: Allergan Sales, LLC
    Inventors: Chin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
  • Ketorolac tromethamine compositions for treating or preventing ocular pain
    Patent number: 8648107
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: February 11, 2014
    Assignee: Allergan Sales, LLC
    Inventors: Christopher A. Muller, Janet K. Cheetham, Teresa H. Kuan, David F. Power
  • COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE
    Publication number: 20130324534
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Application
    Filed: August 1, 2013
    Publication date: December 5, 2013
    Applicant: Allergan Sales, LLC
    Inventors: Chin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
  • Ketorolac tromethamine compositions for treating or preventing ocular pain
    Patent number: 8541463
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: September 24, 2013
    Assignee: Allergan Sales, LLC
    Inventors: Christopher A. Muller, Janet K. Cheetham, Teresa H. Kuan, David F. Power
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20130203833
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 8, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: Allergan Sales, LLC
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20130203834
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 8, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: ALLERGAN SALES, LLC
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20130197051
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Application
    Filed: March 13, 2013
    Publication date: August 1, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: Allergan Sales, LLC
  • COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE
    Publication number: 20130196995
    Abstract: Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
    Type: Application
    Filed: March 13, 2013
    Publication date: August 1, 2013
    Applicant: ALLERGAN SALES, LLC
    Inventor: Allergan Sales, LLC
  • Ketorolac tromethamine compositions for treating or preventing ocular pain
    Patent number: 8377982
    Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: February 19, 2013
    Assignee: Allergan Sales, LLC
    Inventors: Christopher A. Muller, Janet K. Cheetam, Teresa H. Kuan
  • (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
    Patent number: 6541504
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: April 1, 2003
    Assignee: Allergan Sales, LLC
    Inventors: Steven W. Andrews, Julie A. Wurster, Clarence E. Hull, III, Edward H. Wang, Thomas Malone, Xialing Guo, Zhen Zhu
  • Organosilyl compounds having nuclear hormone receptor modulating activity
    Patent number: 6452032
    Abstract: Silicone-containing organic compounds useful as modulators of mammalian nuclear hormone receptors, particularly the retinoid receptors and the farnesoid receptors.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: September 17, 2002
    Assignee: Allergan Sales, LLC
    Inventors: Richard L. Beard, Michael E. Garst, Roshantha A. Chandraratna
  • Substituted aryl or heteroarylamides having retinoid-like biological activity
    Patent number: 6437129
    Abstract: Compounds of the formula wherein X, L, Y, A, B, W, R1, m, p and r are defined above.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: August 20, 2002
    Assignee: Allergan Sales, LLC
    Inventors: Min Teng, Tien T. Duong, Roshantha A. Chandraratna